Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 20.55
-0.97 (-4.51%)
Oct 28, 2026, 3:00 PM CST
SHA:688321 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,090 | 11,916 | 7,577 | 8,945 | 8,945 | 14,379 | |
Market Cap Growth | -23.03% | 57.27% | -15.30% | 0.00% | -37.79% | -5.24% |
Enterprise Value | 9,361 | 12,829 | 8,392 | 9,066 | 8,924 | 14,093 |
Last Close Price | 21.52 | 29.17 | 18.55 | 21.91 | 21.94 | 34.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 123.38 | 233.84 | - | 100.69 | 511.60 | 654.85 |
Forward PE | - | 262.00 | 262.00 | 94.41 | 114.18 | 160.97 |
PS Ratio | 8.84 | 13.09 | 11.52 | 17.08 | 16.88 | 33.41 |
PB Ratio | 3.73 | 7.33 | 4.79 | 5.23 | 5.68 | 10.14 |
P/TBV Ratio | 4.41 | 9.86 | 6.69 | 5.86 | 6.82 | 11.97 |
P/OCF Ratio | 59.53 | 122.89 | 99.53 | - | 206.61 | 115.23 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.10 | 14.10 | 12.75 | 17.31 | 16.84 | 32.74 |
EV/EBITDA Ratio | 47.91 | 83.81 | - | - | 208.74 | 23744.86 |
EV/EBIT Ratio | 78.52 | 150.37 | - | - | 1532.22 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.57 | 0.95 | 0.84 | 0.63 | 0.51 | 0.11 |
Debt / EBITDA Ratio | 7.12 | 9.95 | - | - | 18.13 | 22.66 |
Net Debt / Equity Ratio | 0.11 | 0.56 | 0.55 | 0.13 | -0.11 | -0.23 |
Net Debt / EBITDA Ratio | 1.35 | 5.90 | -218.79 | -1.61 | -4.07 | -562.02 |
Net Debt / FCF Ratio | -1.68 | -11.06 | -4.49 | -0.59 | 0.49 | 2.04 |
Asset Turnover | 0.27 | 0.26 | 0.20 | 0.17 | 0.22 | 0.24 |
Inventory Turnover | 2.44 | 2.38 | 1.99 | 1.51 | 1.37 | 1.56 |
Quick Ratio | 2.46 | 1.12 | 1.43 | 2.74 | 2.12 | 2.05 |
Current Ratio | 2.91 | 1.40 | 2.40 | 2.89 | 2.19 | 2.17 |
Return on Equity (ROE) | 3.39% | 3.18% | -6.96% | 2.99% | 0.86% | 1.51% |
Return on Assets (ROA) | 1.92% | 1.54% | -1.17% | -3.77% | 0.15% | -0.45% |
Return on Invested Capital (ROIC) | 4.67% | 3.43% | -2.77% | -5.58% | 0.40% | -1.35% |
Return on Capital Employed (ROCE) | 3.20% | 3.00% | -2.20% | -6.50% | 0.20% | -0.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.81% | 0.43% | -1.51% | 0.99% | 0.19% | 0.15% |
FCF Yield | -1.69% | -0.69% | -2.54% | -4.32% | -3.99% | -1.14% |
Dividend Yield | 0.28% | 0.20% | - | - | - | - |
Payout Ratio | 47.30% | 62.29% | - | 21.10% | 69.58% | 19.24% |
Buyback Yield / Dilution | -5.04% | 0.08% | 0.06% | -0.40% | 0.75% | 0.10% |
Total Shareholder Return | -4.77% | 0.28% | 0.06% | -0.40% | 0.75% | 0.10% |